Related Funds
Fund Name | Location |
All On | - |
Alpine BioVentures | Seattle, United States, Washington |
Bestar Consultant | Beijing, Beijing, China |
East Midlands Early Growth Fund | England, Nottingham, United Kingdom |
Government of Alberta | Alberta, Canada, Saint Albert |
IOP Capital | Charleston, South Carolina, United States |
Legend Ventures | Bethesda, Maryland, United States |
Lhasa Zidong Technology | Chengguan District, China, Lhasa |
Littlejohn & Co | Connecticut, Greenwich, United States |
Might Electronic | Hsinchu, Taiwan, Taiwan Province |
Mingde Holdings | - |
OnVista Group | Cologne, Germany, Nordrhein-Westfalen |
ORIX Asia Capital Ltd | China, Hong Kong, Hong Kong Island |
Power Energy Eagle Creek | - |
Procom Venture | Norway, Rogaland, Stavanger |
Spring Point Partners | Pennsylvania, Philadelphia, United States |
The Rose-Hulman Institute of Technology | Indiana, Terre Haute, United States |
Tongsheng Capital | - |
Trinad Capital | California, Los Angeles, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Xforceplus | 04 Sep 2018 | Shanghai, China | |||
$5M | 28 Feb 2017 | Vancouver, British Columbia, Canada | |||
Virogin Biotech | $7M | 21 Mar 2016 | Vancouver, British Columbia, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Xforceplus | 04 Sep 2018 | Shanghai, China | |||
$5M | 28 Feb 2017 | Vancouver, British Columbia, Canada | |||
Virogin Biotech | $7M | 21 Mar 2016 | Vancouver, British Columbia, Canada |